Metabolic syndrome is a risk factor for contrast-induced nephropathy after percutaneous coronary intervention

被引：0
|
作者：
Ozcan, O. U. [1 ]
Er, H. Adanir [1 ]
Gulec, S. [1 ]
Kaya, C. Tulunay [1 ]
Akbulut, I. M. [1 ]
Baris, V. O. [1 ]
Atmaca, Y. [1 ]
Erol, C. [1 ]
机构：
[1] Ankara Univ, Fac Med, Dept Cardiol, TR-06100 Ankara, Turkey
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6089
引用
收藏
页码：1071 / 1071
页数：1
相关论文
共 50 条
  • [1] Anemia is a novel risk factor for contrast-induced nephropathy after percutaneous coronary intervention
    Nikolsky, E
    Mehran, R
    Lasic, Z
    Weisz, G
    Negoita, M
    Na, Y
    Krieger, CL
    Dunne-Tramis, AM
    Sikand, R
    Gilutz, Y
    Kesanakurthy, S
    Mogg, M
    Raj, N
    Stone, GW
    Moses, JW
    Leon, MB
    Dangas, GD
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 23E - 24E
  • [2] Risk scores for contrast-induced nephropathy after percutaneous coronary intervention
    Trio, Olimpia
    Ando, Giuseppe
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 225 : 46 - 46
  • [3] Risk score of contrast-induced nephropathy in patients after percutaneous coronary intervention
    Limbong, Morlim
    Herry, Yan
    Ardhianto, Pipin
    Suhartono
    BALI MEDICAL JOURNAL, 2021, 10 (01) : 400 - 404
  • [4] Novel risk score of contrast-induced nephropathy after percutaneous coronary intervention
    Ji, Ling
    Su, XiaoFeng
    Qin, Wei
    Mi, XuHua
    Liu, Fei
    Tang, XiaoHong
    Li, Zi
    Yang, LiChuan
    NEPHROLOGY, 2015, 20 (08) : 544 - 551
  • [5] Risk Factors Associated With Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention
    Kumar, Dileep
    Liaquat, Hussain
    Sial, Jawaid A.
    Saghir, Tahir
    Kumari, Rekha
    Kumar, Hitesh
    Karim, Musa
    Rai, Kelash
    Bai, Reeta
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [6] Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis
    Wang, Jing
    Zhang, Chunyu
    Liu, Zhina
    Bai, Yanping
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (04)
  • [7] Contrast-induced nephropathy in primary percutaneous coronary intervention
    Gallagher, Sean
    Knight, Charles
    HEART, 2011, 97 (21) : 1723 - 1725
  • [8] Contrast-induced nephropathy after primary percutaneous coronary intervention; diabetes mellitus affects development of contrast-induced nephropathy
    Nanasato, M.
    Matsumoto, M.
    Yamamoto, T.
    Aoyama, Y.
    Ogura, Y.
    Suzuki, H.
    Muramatsu, T.
    Tatematsu, Y.
    Yoshida, Y.
    Hirayama, H.
    EUROPEAN HEART JOURNAL, 2007, 28 : 133 - 133
  • [9] Impact of Metabolic Syndrome on Development of Contrast-Induced Nephropathy After Elective Percutaneous Coronary Intervention Among Nondiabetic Patients
    Ozcan, Ozgur Ulas
    Er, Hacer Adanir
    Gulec, Sadi
    Ustun, Elif Ezgi
    Gerede, Demet Menekse
    Goksuluk, Huseyin
    Kaya, Cansin Tulunay
    Erol, Cetin
    CLINICAL CARDIOLOGY, 2015, 38 (03) : 150 - 156
  • [10] Validation of a New Risk Score to Predict Contrast-Induced Nephropathy After Percutaneous Coronary Intervention
    Tziakas, Dimittios
    Chalikias, Georgios
    Stakos, Dimitrios
    Altun, Armagan
    Sivri, Nasir
    Yetkin, Ertan
    Gur, Mustafa
    Stankovic, Goran
    Mehmedbegovic, Zlatko
    Voudris, Vassilis
    Chatzikyriakou, Sofia
    Garcia-Moll, Xavier
    Serra, Antonio
    Passadakis, Ploumis
    Thodis, Elias
    Vargemezis, Vassilis
    Kaski, Juan Carlos
    Konstantinides, Stavros
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (09): : 1487 - 1493
12345